AnalytiCon Discovery
Latest round
- Series C
Last raised
- Apr 2005
Total raised
- $3M
Investors
- 2
About AnalytiCon Discovery
Founded in 2000 in Potsdam, Germany, AnalytiCon Discovery GmbH develops natural products targeting pharmaceutical, cosmetic, and nutritional applications. The company was acquired by BRAIN AG, part of MIG Fonds, in July 2014. The CEO is Lutz Müller-Kuhrt, who has a history of founding companies in the natural product sector.AnalytiCon Discovery specializes in the research and development of natural products, focusing on pharmaceutical, cosmetic, and nutritional applications. Their core offerings include comprehensive screening libraries that facilitate the discovery of novel compounds, aimed at addressing various health and wellness challenges. The company serves research institutions, pharmaceutical companies, and manufacturers in the cosmetic and nutritional sectors, enabling them to enhance their product lines.AnalytiCon Discovery generates revenue through a structured B2B model, focusing on partnerships and collaborations within the pharmaceutical, cosmetic, and nutritional industries. Revenue streams include fees for access to their screening libraries and potential royalties from products developed using their technologies. Their established relationships underscore the value of their proprietary products and services, although specific pricing details are not disclosed.AnalytiCon Discovery plans to enhance its product offerings and expand into new markets, specifically targeting regions in Asia and North America by 2025.000 mn will facilitate these initiatives, allowing for the development of new products designed to address emerging health and wellness challenges. This strategic direction follows their acquisition by BRAIN AG in July 2014 and reflects a commitment to leveraging their expertise in natural products to drive growth.
Who invested in AnalytiCon Discovery
2 investors across 1 round
See all investors in AnalytiCon Discovery
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Apr 28, 2005
Amount
$3M
Investors
Questions about AnalytiCon Discovery
Who invested in AnalytiCon Discovery?
AnalytiCon Discovery has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AnalytiCon Discovery raised?
AnalytiCon Discovery has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AnalytiCon Discovery last raise money?
AnalytiCon Discovery's most recent round on record is a Series C, in Apr 2005.
What does AnalytiCon Discovery do?
Founded in 2000 in Potsdam, Germany, AnalytiCon Discovery GmbH develops natural products targeting pharmaceutical, cosmetic, and nutritional applications.
Where is AnalytiCon Discovery headquartered?
AnalytiCon Discovery is headquartered in Potsdam, Germany.
Which VCs invest in companies like AnalytiCon Discovery?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at AnalytiCon Discovery's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like AnalytiCon Discovery? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.